| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.011 | 2.794 | 6.174 | 9.593 | 29.516 |
| Total Income - EUR | - | - | - | - | - | 1.022 | 3.149 | 6.347 | 9.766 | 30.190 |
| Total Expenses - EUR | - | - | - | - | - | 1.905 | 15.070 | 14.224 | 18.089 | 32.063 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -884 | -11.921 | -7.878 | -8.323 | -1.873 |
| Net Profit/Loss - EUR | - | - | - | - | - | -914 | -12.005 | -8.063 | -8.323 | -1.873 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Saccharomyces S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 953 | 1.342 | 1.260 | 1.217 | 938 |
| Current Assets | - | - | - | - | - | 21.153 | 29.978 | 23.622 | 50.083 | 52.096 |
| Inventories | - | - | - | - | - | 0 | 14.409 | 17.345 | 37.267 | 33.492 |
| Receivables | - | - | - | - | - | 602 | 1.764 | 1.792 | 4.536 | 8.198 |
| Cash | - | - | - | - | - | 20.552 | 13.805 | 4.485 | 8.280 | 10.405 |
| Shareholders Funds | - | - | - | - | - | -873 | -12.858 | -20.961 | -29.221 | -30.930 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 22.979 | 44.179 | 45.844 | 80.520 | 83.964 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4634 - 4634" | |||||||||
| CAEN Financial Year |
4634
|
|||||||||
Comments - Saccharomyces S.r.l.